Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1321 entries
Sorted by: Best Match Show Resources per page
Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure.

Current treatment options in cardiovascular medicine

Grayburn RL, Kaka Y, Tang WH.
PMID: 24874028
Curr Treat Options Cardiovasc Med. 2014 Jul;16(7):322. doi: 10.1007/s11936-014-0322-5.

OPINION STATEMENT: Central sleep apnea (CSA) is a common and under-diagnosed condition commonly associated with Cheyne-Stokes respiration. It is particularly prevalent in the heart failure population affecting up to 40 % of all patients with heart failure. The pathophysiology...

Cite
Grayburn RL, Kaka Y, Tang WH. Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure. Curr Treat Options Cardiovasc Med. 2014;16(7):322doi: 10.1007/s11936-014-0322-5.
Grayburn, R. L., Kaka, Y., & Tang, W. H. (2014). Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure. Current treatment options in cardiovascular medicine, 16(7), 322. https://doi.org/10.1007/s11936-014-0322-5
Grayburn, Ryan L, et al. "Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure." Current treatment options in cardiovascular medicine vol. 16,7 (2014): 322. doi: https://doi.org/10.1007/s11936-014-0322-5
Grayburn RL, Kaka Y, Tang WH. Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure. Curr Treat Options Cardiovasc Med. 2014 Jul;16(7):322. doi: 10.1007/s11936-014-0322-5. PMID: 24874028; PMCID: PMC4102926.
Copy Download .nbib Format: NLM
Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?.

Current treatment options in cardiovascular medicine

Conti S, Verma A.
PMID: 28447320
Curr Treat Options Cardiovasc Med. 2017 May;19(5):38. doi: 10.1007/s11936-017-0537-3.

OPINION STATEMENT: Atrial fibrillation is the most common cardiac arrhythmia and the number of patients is expected to continuously increase in the next years. Catheter ablation is an effective, safe, and well-established treatment for patient with symptomatic and drug-resistant...

Cite
Conti S, Verma A. Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?. Curr Treat Options Cardiovasc Med. 2017;19(5):38doi: 10.1007/s11936-017-0537-3.
Conti, S., & Verma, A. (2017). Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?. Current treatment options in cardiovascular medicine, 19(5), 38. https://doi.org/10.1007/s11936-017-0537-3
Conti, Sergio, and Verma, Atul. "Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?." Current treatment options in cardiovascular medicine vol. 19,5 (2017): 38. doi: https://doi.org/10.1007/s11936-017-0537-3
Conti S, Verma A. Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?. Curr Treat Options Cardiovasc Med. 2017 May;19(5):38. doi: 10.1007/s11936-017-0537-3. PMID: 28447320.
Copy Download .nbib Format: NLM
Adult With Congenital Heart Disease in Developing Country: Scope, Challenges and Possible Solutions.

Current treatment options in cardiovascular medicine

Saxena A.
PMID: 26369545
Curr Treat Options Cardiovasc Med. 2015 Nov;17(11):46. doi: 10.1007/s11936-015-0408-8.

OPINION STATEMENT: Adults with congenital heart disease (CHD) are rapidly increasing in numbers in developed countries where facilities for interventions for CHD are available to infants and children. Over 90 % of children survive to adulthood in these countries....

Cite
Saxena A. Adult With Congenital Heart Disease in Developing Country: Scope, Challenges and Possible Solutions. Curr Treat Options Cardiovasc Med. 2015;17(11):46doi: 10.1007/s11936-015-0408-8.
Saxena, A. (2015). Adult With Congenital Heart Disease in Developing Country: Scope, Challenges and Possible Solutions. Current treatment options in cardiovascular medicine, 17(11), 46. https://doi.org/10.1007/s11936-015-0408-8
Saxena, Anita. "Adult With Congenital Heart Disease in Developing Country: Scope, Challenges and Possible Solutions." Current treatment options in cardiovascular medicine vol. 17,11 (2015): 46. doi: https://doi.org/10.1007/s11936-015-0408-8
Saxena A. Adult With Congenital Heart Disease in Developing Country: Scope, Challenges and Possible Solutions. Curr Treat Options Cardiovasc Med. 2015 Nov;17(11):46. doi: 10.1007/s11936-015-0408-8. PMID: 26369545.
Copy Download .nbib Format: NLM
Multimodality Imaging of the Right Ventricle.

Current treatment options in cardiovascular medicine

Abouzeid CM, Shah T, Johri A, Weinsaft JW, Kim J.
PMID: 28948501
Curr Treat Options Cardiovasc Med. 2017 Sep 25;19(11):82. doi: 10.1007/s11936-017-0584-9.

OPINION STATEMENT: Right ventricular (RV) structure and function is clinically important in a wide range of conditions. While conventional echocardiography (echo) methods are widely used, its limitations in RV assessment due its complex geometry are well recognized. New applications...

Cite
Abouzeid CM, Shah T, Johri A, et al. Multimodality Imaging of the Right Ventricle. Curr Treat Options Cardiovasc Med. 2017;19(11):82doi: 10.1007/s11936-017-0584-9.
Abouzeid, C. M., Shah, T., Johri, A., Weinsaft, J. W., & Kim, J. (2017). Multimodality Imaging of the Right Ventricle. Current treatment options in cardiovascular medicine, 19(11), 82. https://doi.org/10.1007/s11936-017-0584-9
Abouzeid, Christiane M, et al. "Multimodality Imaging of the Right Ventricle." Current treatment options in cardiovascular medicine vol. 19,11 (2017): 82. doi: https://doi.org/10.1007/s11936-017-0584-9
Abouzeid CM, Shah T, Johri A, Weinsaft JW, Kim J. Multimodality Imaging of the Right Ventricle. Curr Treat Options Cardiovasc Med. 2017 Sep 25;19(11):82. doi: 10.1007/s11936-017-0584-9. PMID: 28948501; PMCID: PMC6002848.
Copy Download .nbib Format: NLM
Management of Cognitive Impairment in Heart Failure.

Current treatment options in cardiovascular medicine

Yzeiraj E, Tam DM, Gorodeski EZ.
PMID: 26747626
Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):4. doi: 10.1007/s11936-015-0425-7.

OPINION STATEMENT: Cognitive impairment (CI) is an inclusive term to describe trouble with memory, learning, concentration, or decision-making. CI is highly prevalent in patients with heart failure (HF) and is known to be associated with a variety of poor...

Cite
Yzeiraj E, Tam DM, Gorodeski EZ. Management of Cognitive Impairment in Heart Failure. Curr Treat Options Cardiovasc Med. 2016;18(1):4doi: 10.1007/s11936-015-0425-7.
Yzeiraj, E., Tam, D. M., & Gorodeski, E. Z. (2016). Management of Cognitive Impairment in Heart Failure. Current treatment options in cardiovascular medicine, 18(1), 4. https://doi.org/10.1007/s11936-015-0425-7
Yzeiraj, Edlira, et al. "Management of Cognitive Impairment in Heart Failure." Current treatment options in cardiovascular medicine vol. 18,1 (2016): 4. doi: https://doi.org/10.1007/s11936-015-0425-7
Yzeiraj E, Tam DM, Gorodeski EZ. Management of Cognitive Impairment in Heart Failure. Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):4. doi: 10.1007/s11936-015-0425-7. PMID: 26747626.
Copy Download .nbib Format: NLM
Approach to Treatment of Bifurcation Lesions.

Current treatment options in cardiovascular medicine

Alomari I, Seto A.
PMID: 26747627
Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):5. doi: 10.1007/s11936-015-0428-4.

OPINION STATEMENT: Bifurcation lesions are frequently encountered in the cath lab [1] and remain a challenge for conventional percutaneous coronary intervention (PCI) techniques. Although provisional stenting remains the default approach for most bifurcation lesions [2-6], the two-stent technique is...

Cite
Alomari I, Seto A. Approach to Treatment of Bifurcation Lesions. Curr Treat Options Cardiovasc Med. 2016;18(1):5doi: 10.1007/s11936-015-0428-4.
Alomari, I., & Seto, A. (2016). Approach to Treatment of Bifurcation Lesions. Current treatment options in cardiovascular medicine, 18(1), 5. https://doi.org/10.1007/s11936-015-0428-4
Alomari, Ihab, and Seto, Arnold. "Approach to Treatment of Bifurcation Lesions." Current treatment options in cardiovascular medicine vol. 18,1 (2016): 5. doi: https://doi.org/10.1007/s11936-015-0428-4
Alomari I, Seto A. Approach to Treatment of Bifurcation Lesions. Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):5. doi: 10.1007/s11936-015-0428-4. PMID: 26747627.
Copy Download .nbib Format: NLM
Ebstein anomaly: assessment, management, and timing of intervention.

Current treatment options in cardiovascular medicine

Arya P, Beroukhim R.
PMID: 25145925
Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):338. doi: 10.1007/s11936-014-0338-x.

OPINION STATEMENT: Ebstein anomaly is a developmental abnormality of the tricuspid valve and right ventricle that results in tricuspid regurgitation and right heart enlargement. Because of the variation in clinical severity and associated findings, patients require a detailed, well-tailored...

Cite
Arya P, Beroukhim R. Ebstein anomaly: assessment, management, and timing of intervention. Curr Treat Options Cardiovasc Med. 2014;16(10):338doi: 10.1007/s11936-014-0338-x.
Arya, P., & Beroukhim, R. (2014). Ebstein anomaly: assessment, management, and timing of intervention. Current treatment options in cardiovascular medicine, 16(10), 338. https://doi.org/10.1007/s11936-014-0338-x
Arya, Puneeta, and Beroukhim, Rebecca. "Ebstein anomaly: assessment, management, and timing of intervention." Current treatment options in cardiovascular medicine vol. 16,10 (2014): 338. doi: https://doi.org/10.1007/s11936-014-0338-x
Arya P, Beroukhim R. Ebstein anomaly: assessment, management, and timing of intervention. Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):338. doi: 10.1007/s11936-014-0338-x. PMID: 25145925.
Copy Download .nbib Format: NLM
Desensitization Strategies Pre- and Post-Cardiac Transplantation.

Current treatment options in cardiovascular medicine

Cole RM, Kobashigawa JA.
PMID: 26781656
Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):8. doi: 10.1007/s11936-015-0431-9.

OPINION STATEMENT: Panel reactive antibody (PRA) testing has become standard in the evaluation of patients prior to cardiac transplant. Sensitizing events such as blood transfusions, which result in the accumulation of pre-transplant antibodies, should be avoided as clinically feasible....

Cite
Cole RM, Kobashigawa JA. Desensitization Strategies Pre- and Post-Cardiac Transplantation. Curr Treat Options Cardiovasc Med. 2016;18(2):8doi: 10.1007/s11936-015-0431-9.
Cole, R. M., & Kobashigawa, J. A. (2016). Desensitization Strategies Pre- and Post-Cardiac Transplantation. Current treatment options in cardiovascular medicine, 18(2), 8. https://doi.org/10.1007/s11936-015-0431-9
Cole, Robert M, and Kobashigawa, Jon A. "Desensitization Strategies Pre- and Post-Cardiac Transplantation." Current treatment options in cardiovascular medicine vol. 18,2 (2016): 8. doi: https://doi.org/10.1007/s11936-015-0431-9
Cole RM, Kobashigawa JA. Desensitization Strategies Pre- and Post-Cardiac Transplantation. Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):8. doi: 10.1007/s11936-015-0431-9. PMID: 26781656.
Copy Download .nbib Format: NLM
Early ventricular remodeling and dysfunction in obese children and adolescents.

Current treatment options in cardiovascular medicine

Sanchez AA, Singh GK.
PMID: 25143118
Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):340. doi: 10.1007/s11936-014-0340-3.

OPINION STATEMENT: Obesity is an independent predictor of heart failure in adults. Obese individuals have increased hemodynamic load and neuro-hormonal activation that contribute, but cannot entirely explain the reported changes in ventricular structure and function leading to heart failure....

Cite
Sanchez AA, Singh GK. Early ventricular remodeling and dysfunction in obese children and adolescents. Curr Treat Options Cardiovasc Med. 2014;16(10):340doi: 10.1007/s11936-014-0340-3.
Sanchez, A. A., & Singh, G. K. (2014). Early ventricular remodeling and dysfunction in obese children and adolescents. Current treatment options in cardiovascular medicine, 16(10), 340. https://doi.org/10.1007/s11936-014-0340-3
Sanchez, Aura A, and Singh, Gautam K. "Early ventricular remodeling and dysfunction in obese children and adolescents." Current treatment options in cardiovascular medicine vol. 16,10 (2014): 340. doi: https://doi.org/10.1007/s11936-014-0340-3
Sanchez AA, Singh GK. Early ventricular remodeling and dysfunction in obese children and adolescents. Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):340. doi: 10.1007/s11936-014-0340-3. PMID: 25143118.
Copy Download .nbib Format: NLM
Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality.

Current treatment options in cardiovascular medicine

Liao D, Rodríguez-Colón SM, He F, Bixler EO.
PMID: 25143120
Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):342. doi: 10.1007/s11936-014-0342-1.

OPINION STATEMENT: The epidemic of childhood obesity is becoming a major predictor for risk of cardiovascular diseases (CVD) and mortality during adulthood. Alterations in the morphology of the heart due to obesity could be a predictor for the dysfunction...

Cite
Liao D, Rodríguez-Colón SM, He F, et al. Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality. Curr Treat Options Cardiovasc Med. 2014;16(10):342doi: 10.1007/s11936-014-0342-1.
Liao, D., Rodríguez-Colón, S. M., He, F., & Bixler, E. O. (2014). Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality. Current treatment options in cardiovascular medicine, 16(10), 342. https://doi.org/10.1007/s11936-014-0342-1
Liao, Duanping, et al. "Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality." Current treatment options in cardiovascular medicine vol. 16,10 (2014): 342. doi: https://doi.org/10.1007/s11936-014-0342-1
Liao D, Rodríguez-Colón SM, He F, Bixler EO. Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality. Curr Treat Options Cardiovasc Med. 2014 Oct;16(10):342. doi: 10.1007/s11936-014-0342-1. PMID: 25143120; PMCID: PMC4159679.
Copy Download .nbib Format: NLM
Approach to Lower Extremity Edema.

Current treatment options in cardiovascular medicine

Ratchford EV, Evans NS.
PMID: 28290004
Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):16. doi: 10.1007/s11936-017-0518-6.

OPINION STATEMENT: Lower extremity edema is extremely common among patients seen across multiple specialties. The differential diagnosis is broad and ranges from simple dependent edema to more complex conditions such as chronic venous disease and lymphedema. Several key features...

Cite
Ratchford EV, Evans NS. Approach to Lower Extremity Edema. Curr Treat Options Cardiovasc Med. 2017;19(3):16doi: 10.1007/s11936-017-0518-6.
Ratchford, E. V., & Evans, N. S. (2017). Approach to Lower Extremity Edema. Current treatment options in cardiovascular medicine, 19(3), 16. https://doi.org/10.1007/s11936-017-0518-6
Ratchford, Elizabeth V, and Evans, Natalie S. "Approach to Lower Extremity Edema." Current treatment options in cardiovascular medicine vol. 19,3 (2017): 16. doi: https://doi.org/10.1007/s11936-017-0518-6
Ratchford EV, Evans NS. Approach to Lower Extremity Edema. Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):16. doi: 10.1007/s11936-017-0518-6. PMID: 28290004.
Copy Download .nbib Format: NLM
Exercise Testing and Stress Imaging in Mitral Valve Disease.

Current treatment options in cardiovascular medicine

Voilliot D, Lancellotti P.
PMID: 28290006
Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):17. doi: 10.1007/s11936-017-0516-8.

OPINION STATEMENT: Mitral valve disease represented by mitral stenosis and mitral regurgitation is the second most frequent valvulopathy. Mitral stenosis leads to an increased left atrial pressure whereas mitral regurgitation leads to an increased left atrial pressure associated with...

Cite
Voilliot D, Lancellotti P. Exercise Testing and Stress Imaging in Mitral Valve Disease. Curr Treat Options Cardiovasc Med. 2017;19(3):17doi: 10.1007/s11936-017-0516-8.
Voilliot, D., & Lancellotti, P. (2017). Exercise Testing and Stress Imaging in Mitral Valve Disease. Current treatment options in cardiovascular medicine, 19(3), 17. https://doi.org/10.1007/s11936-017-0516-8
Voilliot, Damien, and Lancellotti, Patrizio. "Exercise Testing and Stress Imaging in Mitral Valve Disease." Current treatment options in cardiovascular medicine vol. 19,3 (2017): 17. doi: https://doi.org/10.1007/s11936-017-0516-8
Voilliot D, Lancellotti P. Exercise Testing and Stress Imaging in Mitral Valve Disease. Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):17. doi: 10.1007/s11936-017-0516-8. PMID: 28290006.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1321 entries